Patricia Carr - 04 Nov 2026 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

SEC form
4
Accepted by SEC
06 Nov 2026, 17:19:57 UTC
Prior SEC filing
09 Mar 2026
Source filing
View source filing
Filing notes and source

Key filing fact

Patricia Carr filed Form 4 for Jazz Pharmaceuticals plc (JAZZ) on 06 Nov 2026.

Key facts

  • This page summarizes Patricia Carr's Form 4 filing for Jazz Pharmaceuticals plc (JAZZ).
  • 4 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 06 Nov 2026, 17:19.

Change

  • Previous filing in this sequence was filed on 09 Mar 2026.
  • Current net transaction value: -$326,910.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001784606 Primary reporting owner

Carr Patricia

Relationship
SVP, Chief Accounting Officer

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

JAZZ transaction

Ordinary Shares

Options Exercise

Transaction value
Shares
+1,250
Change %
+19%
Price
$140.03*
Shares after
7,925
Date
04 Nov 2026
Ownership
Direct
Footnotes
F1
JAZZ transaction

Ordinary Shares

Sale

Transaction value
-$289,212
Shares
-1,250
Change %
-16%
Price
$231.37
Shares after
6,675
Date
04 Nov 2026
Ownership
Direct
JAZZ transaction

Ordinary Shares

Sale

Transaction value
-$37,697
Shares
-163
Change %
-2.4%
Price
$231.27
Shares after
6,512
Date
04 Nov 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

JAZZ transaction Derivative

Non-Qualified Stock Option (right to buy)

Options Exercise

Transaction value
Shares
-1,250
Change %
-29%
Price
$0.000000*
Shares after
3,000
Date
04 Nov 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
1,250
Exercise price
$140.03
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The Reporting Person acquired 163 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 29, 2026.

Footnote F2

These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 28, 2019, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .